bioAffinity Technologies (BIAF) Research & Development (2022 - 2025)
Historic Research & Development for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $330589.0.
- bioAffinity Technologies' Research & Development rose 2043.45% to $330589.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 687.66%. This contributed to the annual value of $1.5 million for FY2024, which is 45.7% down from last year.
- Per bioAffinity Technologies' latest filing, its Research & Development stood at $330589.0 for Q3 2025, which was up 2043.45% from $311372.0 recorded in Q2 2025.
- bioAffinity Technologies' Research & Development's 5-year high stood at $450612.0 during Q4 2022, with a 5-year trough of $248419.0 in Q2 2022.
- Its 4-year average for Research & Development is $349142.2, with a median of $335125.0 in 2023.
- In the last 5 years, bioAffinity Technologies' Research & Development skyrocketed by 3490.31% in 2023 and then crashed by 2262.76% in 2025.
- bioAffinity Technologies' Research & Development (Quarter) stood at $450612.0 in 2022, then fell by 3.95% to $432818.0 in 2023, then fell by 9.74% to $390658.0 in 2024, then dropped by 15.38% to $330589.0 in 2025.
- Its Research & Development was $330589.0 in Q3 2025, compared to $311372.0 in Q2 2025 and $367386.0 in Q1 2025.